Published in J Autism Dev Disord on July 01, 2008
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study. Transl Psychiatry (2013) 1.11
Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry (2012) 1.09
Neurobehavioral abnormalities in first-degree relatives of individuals with autism. Arch Gen Psychiatry (2010) 1.00
The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience (2015) 0.99
The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol (2009) 0.91
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. J Neurodev Disord (2009) 0.90
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Res (2011) 0.85
Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) (2011) 0.84
PET tracers for serotonin receptors and their applications. Cent Nerv Syst Agents Med Chem (2014) 0.82
Brief report: Platelet-poor plasma serotonin in autism. J Autism Dev Disord (2012) 0.82
The neuropathology of autism. Scientifica (Cairo) (2012) 0.79
Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder. Autism Res (2014) 0.78
Family analysis of immunoglobulin classes and subclasses in children with autistic disorder. Bosn J Basic Med Sci (2009) 0.77
Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism. Autism Res (2013) 0.76
Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders. J Dev Behav Pediatr (2016) 0.75
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80
The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 21.70
Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med (1995) 12.70
Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord (2003) 6.51
The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord (2006) 5.78
A case-control family history study of autism. J Child Psychol Psychiatry (1994) 4.66
Sex differences in the brain: implications for explaining autism. Science (2005) 4.38
Time to give up on a single explanation for autism. Nat Neurosci (2006) 3.87
Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry (1997) 3.60
Autism. N Engl J Med (1997) 3.32
The broad autism phenotype questionnaire. J Autism Dev Disord (2006) 3.02
Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70
Early social-communicative and cognitive development of younger siblings of children with autism spectrum disorders. Arch Pediatr Adolesc Med (2007) 2.28
A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am J Psychiatry (2007) 2.09
Autism, regression, and the broader autism phenotype. Am J Med Genet (2002) 1.80
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev (2004) 1.76
Psychiatric genetics: search for phenotypes. Trends Neurosci (1998) 1.68
5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A (1998) 1.61
Personality traits of the relatives of autistic probands. Psychol Med (2000) 1.60
Social-cognition and the broad autism phenotype: identifying genetically meaningful phenotypes. J Child Psychol Psychiatry (2007) 1.56
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr (1961) 1.56
Exploring the cognitive phenotype of autism: weak "central coherence" in parents and siblings of children with autism: I. Experimental tests. J Child Psychol Psychiatry (2001) 1.56
Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry (2004) 1.53
Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry (2004) 1.52
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry (1993) 1.52
The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology (2001) 1.46
Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry (2006) 1.44
Serotonin and brain development: role in human developmental diseases. Brain Res Bull (2001) 1.39
Predictors of cognitive test patterns in autism families. J Child Psychol Psychiatry (1999) 1.38
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci (1987) 1.31
Familial factors influence level of functioning in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry (1999) 1.29
Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry (2006) 1.27
Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci (2005) 1.26
Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry (2001) 1.24
Communicative competence in parents of children with autism and parents of children with specific language impairment. J Autism Dev Disord (2006) 1.14
Hippocampus and amygdala volumes in parents of children with autistic disorder. Am J Psychiatry (2004) 1.12
Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. J Neurosci (2004) 1.11
5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology (1996) 1.09
fMRI of parents of children with Asperger Syndrome: a pilot study. Brain Cogn (2006) 1.07
Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry (2006) 1.06
Endophenotypes and child psychiatry. Br J Psychiatry (2001) 1.05
Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience (1987) 1.03
Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci (1993) 1.01
Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry (2002) 1.00
Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet (2002) 0.97
Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry (1989) 0.97
Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cell Mol Neurobiol (2002) 0.95
Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry (1999) 0.94
Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biol Psychiatry (2004) 0.92
PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry (1999) 0.91
Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res (2007) 0.89
Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry (1999) 0.88
A voxel-based morphometry study of gray matter in parents of children with autism. Neuroreport (2006) 0.85
Regulation of central 5-HT2A receptors: a review of in vivo studies. Behav Brain Res (1996) 0.83
Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. Am J Psychiatry (1999) 0.82
Brain anatomy in non-affected parents of autistic probands: a MRI study. Psychol Med (2005) 0.81
Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res (1993) 0.80
Pet studies of serotonin synthesis in the human brain. Adv Exp Med Biol (1999) 0.80
Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. Nucl Med Commun (1997) 0.80
The Emanuel Miller Memorial Lecture 1998. Autism: two-way interplay between research and clinical work. J Child Psychol Psychiatry (1999) 0.79
Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med (1996) 0.78
Serotonin and autism: biochemical and molecular biology features. Psychiatry Res (1996) 0.78
A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. J Neurochem (1990) 0.77
Autism research. Bringing together approaches to pull apart the disorder. Arch Gen Psychiatry (1996) 0.76
A liquid chromatographic-tandem mass spectrometric method for the analysis of serotonin and related indoles in human whole blood. J Anal Toxicol (2003) 0.76
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci (2005) 6.56
Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics (2011) 6.08
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry (2006) 5.23
Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04
Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry (2004) 3.83
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet (2010) 3.73
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry (2012) 3.38
Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29
Human chromosome 7: DNA sequence and biology. Science (2003) 3.02
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol (2003) 2.93
Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology (2008) 2.65
Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol Psychiatry (2007) 2.58
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry (2009) 2.44
A prospective case series of high-risk infants who developed autism. J Autism Dev Disord (2007) 2.35
Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med (2011) 2.29
Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders. J Autism Dev Disord (2012) 2.29
Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) (2003) 2.27
Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet (2009) 2.27
Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders. J Autism Dev Disord (2005) 2.23
The developmental neurobiology of autism spectrum disorder. J Neurosci (2006) 2.21
Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am J Hum Genet (2006) 2.14
Specifying PDD-NOS: a comparison of PDD-NOS, Asperger syndrome, and autism. J Am Acad Child Adolesc Psychiatry (2004) 1.95
Early language and communication development of infants later diagnosed with autism spectrum disorder. J Dev Behav Pediatr (2006) 1.93
Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J Neurosci (2006) 1.86
Beyond autism: a baby siblings research consortium study of high-risk children at three years of age. J Am Acad Child Adolesc Psychiatry (2013) 1.86
The Autism Observation Scale for Infants: scale development and reliability data. J Autism Dev Disord (2007) 1.86
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A (2012) 1.85
Similar developmental trajectories in autism and Asperger syndrome: from early childhood to adolescence. J Child Psychol Psychiatry (2009) 1.83
Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation (2003) 1.83
Investigating the structure of the restricted, repetitive behaviours and interests domain of autism. J Child Psychol Psychiatry (2006) 1.81
Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry (2008) 1.80
Autism spectrum disorder: advances in evidence-based practice. CMAJ (2014) 1.76
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75
Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry (2004) 1.70
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol (2002) 1.68
Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology (2005) 1.66
Genetic and neurodevelopmental influences in autistic disorder. Can J Psychiatry (2003) 1.64
Paternal transmission of fragile X syndrome. Am J Med Genet A (2004) 1.62
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet (2011) 1.58
Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet (2011) 1.56
Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology (2010) 1.56
Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry (2004) 1.53
New recommendations on autism spectrum disorder. BMJ (2011) 1.52
Positive end-expiratory pressure above lower inflection point minimizes influx of activated neutrophils into lung. Crit Care Med (2004) 1.52
Comorbidity of internalizing disorders in children with oppositional defiant disorder. Eur Child Adolesc Psychiatry (2007) 1.50
Longitudinal patterns of repetitive behavior in toddlers with autism. J Child Psychol Psychiatry (2014) 1.44
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Temperament and its relationship to autistic symptoms in a high-risk infant sib cohort. J Abnorm Child Psychol (2009) 1.43
Sex differences in children with autism spectrum disorder identified within a high-risk infant cohort. J Autism Dev Disord (2012) 1.39
Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J Neurosci (2006) 1.36
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
A prospective study of autistic-like traits in unaffected siblings of probands with autism spectrum disorder. JAMA Psychiatry (2013) 1.33
The causes of autism spectrum disorders. BMJ (2003) 1.31
Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry (2009) 1.30
Mother-infant interactions in free-ranging rhesus macaques: relationships between physiological and behavioral variables. Physiol Behav (2008) 1.30
A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3 (Bethesda) (2012) 1.30
Validating the Repetitive Behavior Scale-revised in young children with autism spectrum disorder. J Autism Dev Disord (2010) 1.29
Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res (2011) 1.28
Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry (2005) 1.28
Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics (2008) 1.27
Enhanced salience and emotion recognition in Autism: a PET study. Am J Psychiatry (2003) 1.26
Stereotyped motor behaviors associated with autism in high-risk infants: a pilot videotape analysis of a sibling sample. J Autism Dev Disord (2007) 1.26
Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biol Psychiatry (2008) 1.26
Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry (2010) 1.26
Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes. Hum Mol Genet (2013) 1.26